4//SEC Filing
HALPERN JOHN D 4
Accession 0001062993-22-023351
CIK 0000748592other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 6:05 PM ET
Size
8.5 KB
Accession
0001062993-22-023351
Insider Transaction Report
Form 4
HALPERN JOHN D
10% Owner
Transactions
- Purchase
Common Stock
2022-12-02$3.28/sh+335,920$1,101,818→ 450,961 total(indirect: By Trust) - Purchase
Warrants (Right to Purchase)
2022-12-02$0.13/sh+671,840$83,980→ 671,840 total(indirect: By Trust)Exercise: $3.28From: 2023-06-02Exp: 2028-12-02→ Common Stock (671,840 underlying)
Holdings
- 205
Common Stock
Footnotes (5)
- [F1]Reflects a 1-for-20 reverse stock split effective October 17, 2022.
- [F2]Held by John D. Halpern
- [F3]Each share was purchased as part of a unit consisting of one share and two warrants, for a total purchase price of $3.53 per unit.
- [F4]The reporting persons disclaim beneficial ownership of these shares except to the extent of their pecuniary interest therein, if any.
- [F5]The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation.
Issuer
Eterna Therapeutics Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001234950
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 6:05 PM ET
- Size
- 8.5 KB